Destruction pathway of immune sensitized RBCs, e.g. the mechanism of hemolysis is determined by biological characteristics of the antibody: class, subclass, complement activation ability, specificity, thermal range etc., then by antibody concentracion as well as the stage of the complement activation on RBCs ' membrane. Above mentioned properties of antibodies determine whether RBCs ' destruction occur within circulation (intravascular hemolysis) or is mediated by macrophages of the mononuclear phagocite system (MPS) predominantly of liver and spleen (extravascular hemolysis) 2 . Antibodies that are capable to activate the complement pathway up to final lytic complex (C5b-C9) usually cause the RBCs ' rupture with release of free hemoglobin into the plasma, usually followed by dramatic symptoms and clinical manifestation of the acute hemolytictransfusion reaction (AHTR) 3, 4 . It is most likely for IgG antibodies to cause extravascular hemolysis due to their less ability for complete complement activation. Class IgG is most commonly capable to activate the complement only up to C3 stage and therefore those antibodies are likely to be the cause of extravascular hemolysis with or without clinical manifestation of delayed hemolytic transfusion reaction (DHTR 7, 8, 9 . The Kidd antibodies are very heterogeneous, clinically significant immune antibodies which are produced as a consequence of immunisation by transfusion, pregnancy, rarely by transplantation or as a result of autoimmune process. Despite the fact that Kidd antigens are poor immunogens, Kidd antibodies have been frequently implicated in DHTRs but extremely rare are the cause of AHTRs. Following immunization, Kidd antibodies fall rapidly to undetectable levels in the plasma, therefore they are often difficult to detect [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . The Kidd antibodies are mainly of the class IgG, subclasses IgG1 and IgG3, capable to bind complement up to C3 stage 26, 27 . They might be the cause of the hemolytic disease of the fetus and newborn (HDN) but rarely severe ones 18, 19 .Those antibodies may manifest a dosage effect reacting only with red cells with double doze of the antigen (homozygous cells).
The Kidd antibodies react better on antiglobulin testing with polyspecific anti-IgG + anti-C3 as well as with monospecific anti-C3 since they are usually detected indirectly through the complement that they bind to RBCs, therefore the reaction with monospecific anti-IgG usually lack. These antibodies usually give stronger hemagglutination with enzyme treated test cells 27, 28 . Polyethilene glycol (PEG) antiglobulin technique has been reported to be more sensitive compared to indirect antiglobulin test (IAT) and enzyme technique, in detecting antibodies of the Kidd system [29] [30] [31] 
CASE REPORT AND SEROLOGICAL STUDIES
Mrs. S. J. Aged 64, body weight 53kg, with 6 pregnancies. 2 deliveries, 4 abortions and none RBC transfusions in the history, was admitted to the hospital due to bronchopneumonia and severe anemia.
On admittance hemoglobin (Hb) level was 63g/L and hematocrit (Ht) 0,21L/L.
Diagnostic esophagogastroduodenoscopia was performed and showed duodenitis erosiva withouth gastrointestinal bleeding. On Day 1 routine serologic testing was performed and showed that the patient was group O RhD positive with negative polyspecific direct antiglobulin test (DAT) in the standard tube test. Routine antibody screen was also negative with enzyme treated test cells (IDDiaCell I+II+III, lot N 0 4519.65.01/02) using natural gel cards.
On Since the policy of transfusion laboratories for pretransfusion testing is to keep the crossmatched samples for three weeks, the patient 
DISCUSSION
Kidd antibodies are known to be associated with DTHRs, wich generally occur due to secondary immune responses 29 .In our case the patient was obviously primarily immunized to Jk a antigen many years ago through one of the six pregnancies.
Kidd antibodies are well known for their tendency to fall rapidly to very low levels in the Plasma. Our case is in accordance with previous reports since they haven ' t been detected in the patient ' s plasma in serologic testing even with sensitive serologic techniques, performed prior transfusion 1, 13, 15 . Our case clearly demonstrates the secondary immune response which had been provoked by the repeated exposure to the Jk a antigen by transfused Jk a + RBCs. The secondary, anamnestic response involves the recognition of the antigen by the persisting B lymphocytes memory pool, followed by proliferation, diferentiation and maturation into plasma cells which produce specific alloantibodies in sufficient quantity capable to cause clinical manifestation of DHTR. In our case the whole process of anamnestic reaction was completed within 96h. A rapid increase in antibody concentration was achieved. Hemolysis of allogenic Jk a + RBCs persisted in the next 72h, with the clinical symptoms and laboratory findings which confirmed clinical DHTR.
Clinical manifestation of DHTR suggested rapid and strong anamnestic immune response as well as efficient destruction and elimination of the "sensitized" RBCs by macrophages of the MPS, which was confirmed with negative DAT on Day 9.
The dosage phenomenon in this alloantiantibody ' s reactivity was shown through the IAT crossmatch by using both the tube and the gel techniques as well as by antibody screening test using papain treated test cells on natural gel card and with non treated cells on LISS/Coombs Dia Med gel cards.
Antibody identification showed most clearly the dosage phenomenon since it yielded very weak agglutination with some heterozygous cells.
In our case the most sensitive technique used in detecting Jk a antibody was GT with enzyme treated red cells. On the other hand, the Dia Med -ID Microtyping Gel System has been shown to be superior to the conventional tube method.
In detection of complement-binding antibodies of the Kidd system it is very important to use the reagent which contains an anti-complement activity.
It is also necessary to emphasize the need of using red cell diluents which don ' t inhibit complement binding of fresh samples. In all serologic procedures we have performed, the in-NBTI manufactured LISS has been used, because it meets all above mentioned requirements.
This case clearly highlights the need of better cooperation between all related medical staff in the course of recognition of adverse effects of hemotherapy, where active role of the specialist of transfusion medicine is a must. REZIME KASNA HEMOLIZNA TRANSFUZIONA REAKCIJA UZROKOVANA ANTI-Jk a ANTITELOM Uvod: Kidd antitela su vrlo heterogena i te{ko se otkrivaju. ^esto su odgovorna za pojavu kasne transfuzione hemolizne reakcije (KTHR). Prikaz slu~aja: Osoba 'enskog pola, starosti 64 godine (trudno}a 6, porodjaja 2, prekida trudno}e 4), sa negativnom transfuziolo{kom anamnezom, hospitalizovana zbog pneumonije i te{ke anemije. Na prijemu, vrednost hemoglobina (Hb) 63g/L i hematokrita (Ht) 0,21L/L. Zbog potrebe za transfundovanjem eritrocita, uzorak krvi je poslat u laboratoriju za serolo{ko testiranje i pripremu krvi za transfuziju. Krvna grupa bolesnice ORh(D) + (poz). Direktan antihumanglobulinski test (DAT) i rutinski skrining antitela (ID-DiaCell I+II+III-P) negativni. Pripremljene su tri jedinice deplazmatisanih eritrocita sa negativnom interreakcijom (klasi~na metoda u epruveti). Bolesnica je primila dve jedinice eritrocita drugog , a tre}u tre}eg dana, bez ispoljavanja nepovoljnih efekata. Vrednosti hematolo{kih specifi~nosti sa ispoljenim fenomenom doze. Tipizacijom je utvrdjeno da su sve tri transfundovane jedinice eritrocita Jk a +, a fenotip eritrocita bolesnice Jk(a-b+). Bolesnica je primila dve jedinice tipiziranih Jk a negativnih deplazmatisanih eritrocita i u dobrom op{tem stanju otpu{tena je ~etrnaestog dana. Zaklju~ak: Pa'ljivo pra}enje klini~kih efekata transfuzije i dobra saradnja sa specijalistima transfuzione medicine je od izuzetne va'nosti u blagovremenom prepoznavanju transfuzionih reakcija.
U transfuziolo{koj praksi, pretransfuzioni uzorak se ~u-va tri nedelje, a interreakcija se izvodi sa uzorcima koji nisu stariji od 24 ~asa odnosno 48 ~asova.
Klju~ne re~i: transfuzija eritrocita, Kidd krvno grupni sistem, komplement, odlo'ena hemoliza
